Market Value765,570,000
Total Holdings59
File Date2021-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
KZR / Kezar Life Sciences, Inc.
NERV / Minerva Neurosciences, Inc.
MCRB / Seres Therapeutics, Inc.
GMTX / Gemini Therapeutics Inc
FGEN / FibroGen, Inc.
TCON / TRACON Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
VSTM / Verastem, Inc.
SIOX / Sio Gene Therapies Inc.
CMRX / Chimerix, Inc.
ADMS / Adamas Pharmaceuticals Inc
AGLE / Aeglea BioTherapeutics Inc
ONCT / Oncternal Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
INFI / Infinity Pharmaceuticals Inc.
PIRS / Pieris Pharmaceuticals, Inc.
MGTA / Magenta Therapeutics Inc
TCDA / Tricida Inc
CNCE / Concert Pharmaceuticals Inc
US28249H1041 / Eidos Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
MYOV / Myovant Sciences Ltd
OM / Outset Medical, Inc.
PRAX / Praxis Precision Medicines, Inc.
US33830X1046 / Five Prime Therapeutics Inc
AKUS / Akouos Inc
CBIO / Crescent Biopharma, Inc.
AFIB / Acutus Medical, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
MEIP / MEI Pharma, Inc.
CDTX / Cidara Therapeutics, Inc.
CCXI / ChemoCentryx Inc
ATXS / Astria Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
OPTN / OptiNose, Inc.
AVTX / Avalo Therapeutics, Inc.
MRUS / Merus N.V.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
CFRX / ContraFect Corp
OCUL / Ocular Therapeutix, Inc.
XOMA / XOMA Royalty Corporation
KALV / KalVista Pharmaceuticals, Inc.
AVEO / AVEO Pharmaceuticals Inc
STXS / Stereotaxis, Inc.
ATXI / Avenue Therapeutics, Inc.
CRDF / Cardiff Oncology, Inc.
APTO / Aptose Biosciences Inc.
SRRA / Sierra Oncology Inc
STRO / Sutro Biopharma, Inc.
LUMO / Lumos Pharma, Inc.
HROW / Harrow, Inc.
NLTX / Neoleukin Therapeutics, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
FBIO / Fortress Biotech, Inc.
FULC / Fulcrum Therapeutics, Inc.
BHVN / Biohaven Ltd.
EPIX / ESSA Pharma Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
TELA / TELA Bio, Inc.
ETON / Eton Pharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.